- Home
- CLNN
CLNN
Clene Inc.
as 05-14-2025 4:00pm EST
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | SALT LAKE CITY |
| Market Cap: | 26.1M | IPO Year: | N/A |
| Target Price: | $40.00 | AVG Volume (30 days): | 74.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.85 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.55 - $9.20 | Next Earning Date: | 05-07-2025 |
| Revenue: | $350,000 | Revenue Growth: | -43.55% |
| Revenue Growth (this year): | -10.53% | Revenue Growth (next year): | 2066.67% |
Latest Clene Inc. News
CLNN Breaking Stock News: Dive into CLNN Ticker-Specific Updates for Smart Investing
Newsfile
7 days ago
Clene Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference
GlobeNewswire
7 days ago
Clene Reports First Quarter 2025 Financial Results and Recent Operating Highlights
GlobeNewswire
a month ago
Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream
GlobeNewswire
a month ago
Clene to Present at the Emerging Growth Conference
GlobeNewswire
a month ago
Clene Presents Evidence of Remyelination and Neuronal Repair With CNM-Au8® Treatment At the American Academy of Neurology Late-Breaking Science Session
GlobeNewswire
a month ago
Clene to Present at the Jones Healthcare and Technology Innovation Conference
NewMediaWire
2 months ago
Clene to Participate in Jones Las Vegas Technology and Innovation Conference on April 8-9, 2025
GlobeNewswire
2 months ago
Clene Reports Full Year 2024 Financial Results and Recent Operating Highlights
Compare CLNN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CLNN Clene Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.